Literature DB >> 28283892

A Review of the Ahmed Glaucoma Valve Implant and Comparison with Other Surgical Operations.

Ivano Riva1, Gloria Roberti1, Andreas Katsanos2, Francesco Oddone1, Luciano Quaranta3.   

Abstract

The Ahmed glaucoma valve (AGV) is a popular glaucoma drainage implant used for the control of intraocular pressure in patients with glaucoma. While in the past AGV implantation was reserved for glaucoma patients poorly controlled after one or more filtration procedures, mounting evidence has recently encouraged its use as a primary surgery in selected cases. AGV has been demonstrated to be safe and effective in reducing intraocular pressure in patients with primary or secondary refractory glaucoma. Compared to other glaucoma surgeries, AGV implantation has shown favorable efficacy and safety. The aim of this article is to review the results of studies directly comparing AGV with other surgical procedures in patients with glaucoma.

Entities:  

Keywords:  Ahmed glaucoma valve; Glaucoma drainage implants; Glaucoma surgery; Glaucoma tubes; Ophthalmology; Trabeculectomy

Mesh:

Year:  2017        PMID: 28283892     DOI: 10.1007/s12325-017-0503-1

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  16 in total

1.  Managing high risk glaucoma with the Ahmed valve implant: 20 years of experience.

Authors:  Tryfon Rotsos; Anastasia Tsioga; Konstantinos Andreanos; Andreas Diagourtas; Petros Petrou; Ilias Georgalas; Dimitrios Papaconstantinou
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

2.  Clinical efficacy of Ahmed glaucoma valve implantation combined with 23-gauge vitrectomy for medically uncontrolled neovascular glaucoma with proliferative diabetic retinopathy.

Authors:  Zhong-Jing Lin; Zheng-Hua Chen; Shou-Yue Huang; Jun Sun; Xi Shen; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

3.  Long-term outcomes of uveitic glaucoma treated with Ahmed valve implant in a series of Chinese patients.

Authors:  Ning Bao; Zheng-Xuan Jiang; Paul Coh; Li-Ming Tao
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

4.  Long-term comparison of the outcomes of Ahmed Glaucoma Valve surgery between glaucoma surgeons and cornea trained surgeons.

Authors:  Ramin Daneshvar; Farshid Karimi; Fatemeh Golami; Seyed Aliasghar Mosavi; Masoud Khorrami-Nejad
Journal:  Int Ophthalmol       Date:  2021-11-01       Impact factor: 2.031

5.  Evaluation of primary Ahmed Glaucoma valve implantation in post-traumatic angle recession glaucoma in Indian eyes.

Authors:  Jaya Kaushik; Jitendra Kumar Singh Parihar; Ankita Singh; Rakesh Shetty; Aanchal Singhal; Y V K Chaitanya; Vaibhav Kumar Jain; Vijay Mathur
Journal:  Int Ophthalmol       Date:  2021-10-14       Impact factor: 2.031

6.  Impact of same-session trabectome surgery on Ahmed glaucoma valve outcomes.

Authors:  Hamed Esfandiari; Tarek Shazly; Priyal Shah; Kiana Hassanpour; Pooya Torkian; Mehdi Yaseri; Nils A Loewen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-30       Impact factor: 3.117

7.  Traumatic corneal perforation with exteriorisation of Ahmed glaucoma valve tube.

Authors:  Suresh Kumar; Parul Ichhpujani; Sahil Thakur; Rohan Bir Singh
Journal:  BMJ Case Rep       Date:  2018-06-11

8.  Comparison of surgical outcomes of trabeculectomy, Ahmed shunt, and Baerveldt shunt in uveitic glaucoma.

Authors:  Audrey Chow; Bruce Burkemper; Rohit Varma; Damien C Rodger; Narsing Rao; Grace M Richter
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-06-18

9.  Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant.

Authors:  Tai Jun Kim; Sohyun Kang; Jin Wook Jeoung; Young Kook Kim; Ki Ho Park
Journal:  BMC Ophthalmol       Date:  2018-02-14       Impact factor: 2.209

10.  Diode laser transscleral cyclophotocoagulation causes intraocular collamer lens displacement in pseudophakic eye: a case report.

Authors:  Wei Wei; Xueqing Yu; Lu Yang; Chan Xiong; Xu Zhang
Journal:  BMC Ophthalmol       Date:  2021-06-29       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.